Home › Atopic Dermatitis (Eczema) › New York › New York City
Atopic Dermatitis (Eczema) clinical trials in New York City, NY
13 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
RecruitingPhase 1Healthy volunteers welcome
- OptiSkin Medical, New York
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Enveda Investigative Site, New York
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
RecruitingPhase 2
- Investigational Site, New York
Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
Recruiting
- Weill Cornell Medicine, New York
- Columbia University Irving Medical Center, New York
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Sadick Research Group, LLC, New York
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Inmagene Site 21, New York
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
RecruitingPhase 3
- Equity Medical /ID# 265814, New York
- Weill Cornell Medicine /ID# 265793, New York
Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
RecruitingPhase 1
- Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology, New York
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
RecruitingPhase 2
- Private Practice - Dr. Bobby Buka, New York
- Icahn School of Medicine at Mount Sinai, New York
- Sadick Research Group, New York
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
RecruitingObservational study
- Galderma Investigational Site - 7051, New York
- Galderma Investigational Site 7109, New York
- Galderma Investigational Site 8279, New York
Allergy and Immunology Natural History Study
RecruitingObservational studyHealthy volunteers welcome
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
RecruitingPhase 2
- Icahn School of Medicine at Mount Sinai, New York
A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
RecruitingObservational studyHealthy volunteers welcome
- Pfizer, New York
Atopic Dermatitis (Eczema) trials in other cities
- Los Angeles, CA11 studies
- Washington, DC11 studies
- San Antonio, TX10 studies
- San Diego, CA10 studies
- Miami, FL9 studies
- Birmingham, AL9 studies
- Dallas, TX8 studies
- Sacramento, CA8 studies
- Huntington Beach, CA8 studies
- Troy, MI8 studies
- Indianapolis, IN7 studies
- Pittsburgh, PA7 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.